Annual Operating Profit
-$350.06 M
-$104.33 M-42.46%
December 31, 2023
Summary
- As of February 25, 2025, RXRX annual operating income is -$350.06 million, with the most recent change of -$104.33 million (-42.46%) on December 31, 2023.
- During the last 3 years, RXRX annual operating profit has fallen by -$265.44 million (-313.71%).
- RXRX annual operating profit is now -460.63% below its all-time high of -$62.44 million, reached on December 31, 2019.
Performance
RXRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$98.35 M
+$2.19 M+2.18%
September 30, 2024
Summary
- As of February 25, 2025, RXRX quarterly operating income is -$98.35 million, with the most recent change of +$2.19 million (+2.18%) on September 30, 2024.
- Over the past year, RXRX quarterly operating profit has stayed the same.
- RXRX quarterly operating profit is now -439.90% below its all-time high of -$18.22 million, reached on June 30, 2020.
Performance
RXRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$394.17 M
+$1.20 M+0.30%
September 30, 2024
Summary
- As of February 25, 2025, RXRX TTM operating income is -$394.17 million, with the most recent change of +$1.20 million (+0.30%) on September 30, 2024.
- Over the past year, RXRX TTM operating profit has stayed the same.
- RXRX TTM operating profit is now -2048.87% below its all-time high of -$18.34 million, reached on March 31, 2020.
Performance
RXRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RXRX Operating Profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -42.5% | 0.0% | 0.0% |
3 y3 years | -313.7% | -61.3% | -60.4% |
5 y5 years | -460.6% | -61.3% | -60.4% |
RXRX Operating Profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -91.5% | at low | -75.7% | +2.2% | -115.7% | +0.3% |
5 y | 5-year | -460.6% | at low | -439.9% | +2.2% | -2048.9% | +0.3% |
alltime | all time | -460.6% | at low | -439.9% | +2.2% | -2048.9% | +0.3% |
Recursion Pharmaceuticals Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$98.35 M(-2.2%) | -$394.17 M(-0.3%) |
Jun 2024 | - | -$100.54 M(+4.4%) | -$395.36 M(+5.0%) |
Mar 2024 | - | -$96.34 M(-2.6%) | -$376.54 M(+7.6%) |
Dec 2023 | -$350.06 M(+42.5%) | -$98.93 M(-0.6%) | -$350.06 M(+12.2%) |
Sep 2023 | - | -$99.55 M(+21.8%) | -$312.11 M(+13.4%) |
Jun 2023 | - | -$81.72 M(+17.0%) | -$275.13 M(+6.0%) |
Mar 2023 | - | -$69.86 M(+14.6%) | -$259.61 M(+5.7%) |
Dec 2022 | -$245.73 M | -$60.98 M(-2.5%) | -$245.73 M(-1.6%) |
Sep 2022 | - | -$62.57 M(-5.5%) | -$249.71 M(+6.9%) |
Jun 2022 | - | -$66.19 M(+18.2%) | -$233.53 M(+12.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$55.98 M(-13.8%) | -$208.27 M(+13.9%) |
Dec 2021 | -$182.78 M(+116.0%) | -$64.96 M(+40.0%) | -$182.78 M(+27.5%) |
Sep 2021 | - | -$46.40 M(+13.4%) | -$143.40 M(+20.0%) |
Jun 2021 | - | -$40.93 M(+34.3%) | -$119.47 M(+23.5%) |
Mar 2021 | - | -$30.48 M(+19.2%) | -$96.76 M(+14.3%) |
Dec 2020 | -$84.61 M(+35.5%) | - | - |
Dec 2020 | - | -$25.58 M(+13.8%) | -$84.61 M(+43.3%) |
Sep 2020 | - | -$22.47 M(+23.4%) | -$59.03 M(+61.5%) |
Jun 2020 | - | -$18.22 M(-0.7%) | -$36.56 M(+99.3%) |
Mar 2020 | - | -$18.34 M | -$18.34 M |
Dec 2019 | -$62.44 M | - | - |
FAQ
- What is Recursion Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual operating profit year-on-year change?
- What is Recursion Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly operating profit year-on-year change?
- What is Recursion Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals TTM operating profit year-on-year change?
What is Recursion Pharmaceuticals annual operating income?
The current annual operating profit of RXRX is -$350.06 M
What is the all time high annual operating profit for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual operating income is -$62.44 M
What is Recursion Pharmaceuticals annual operating profit year-on-year change?
Over the past year, RXRX annual operating income has changed by -$104.33 M (-42.46%)
What is Recursion Pharmaceuticals quarterly operating income?
The current quarterly operating profit of RXRX is -$98.35 M
What is the all time high quarterly operating profit for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly operating income is -$18.22 M
What is Recursion Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, RXRX quarterly operating income has changed by $0.00 (0.00%)
What is Recursion Pharmaceuticals TTM operating income?
The current TTM operating profit of RXRX is -$394.17 M
What is the all time high TTM operating profit for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high TTM operating income is -$18.34 M
What is Recursion Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, RXRX TTM operating income has changed by $0.00 (0.00%)